SCHEMBL9284385

SCHEMBL9284385

CC(C)(C)N(C(=O)O)C1CNc2c(cccc2C(=N)N)C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.32
AURKA O14965 1/20 0.30
HDAC11 Q96DB2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7344883 0.83 EPHX2 (0.30)
SCHEMBL1027767 0.71 NPY5R (0.41)
SCHEMBL18097052 0.67
SCHEMBL1026496 0.66 HTR1A (0.48)
SCHEMBL10617679 0.63 KDM4E (0.36)
SCHEMBL1789638 0.62 TDP2 (0.45)
SCHEMBL7001370 0.62 AURKA (0.40) PARP1AURKA
SCHEMBL7342582 0.61 CHRM3 (0.50)
SCHEMBL1010887 0.60 CTSD (0.31)
SCHEMBL7347949 0.60 DRD2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed